Animal Pharm, 18.12.2018
„Stonehaven Incubate targets pet antimicrobials in latest project“
Stonehaven Incubate has partnered with antimicrobial protein specialist Lysando to develop therapies for companion animal infections. The partners will conduct proof-of-concept trials for topical treatments based on Lysando's Artilysin protein-based antimicrobials.
By Joseph Harvey
Frankfurter Allgemeine Zeitung, 22.2.2018, german language
„The medical sensation“
There is hope for patients, in which the general-purpose drug no longer works: The start-up Lysando achieved great success with Artilysins. But a hurdle has not been overcome in the race against resistant bacteria ...
By Henning Peitsmeier